Pfizer to Exit ViiV Healthcare as GSK and Shionogi Reshape Ownership

Pfizer Inc. (NYSE:PFE) is included among

Dividend Contenders List: Top 20 Stocks.

Reuters reported connected January 20 that Britain’s GSK and Japan’s Shionogi said Pfizer Inc. (NYSE:PFE) volition exit their HIV-focused associated venture, ViiV Healthcare. The transaction values Pfizer’s exit astatine astir $1.9 cardinal and sharply increases Shionogi’s involvement successful the business.

Under the deal, Shionogi volition wage $2.13 cardinal for recently issued shares, lifting its ownership successful ViiV Healthcare to 21.7% from 10%. GSK volition proceed to power the company, keeping its 78.3% bulk stake.

Pfizer volition person $1.88 cardinal for its 11.7% holding. GSK, meanwhile, volition person a $250 cardinal peculiar dividend arsenic ViiV cancels Pfizer’s shares. GSK primitively formed ViiV Healthcare with Pfizer successful 2009, with Shionogi joining the task successful 2012.

The companies said the woody is taxable to regulatory approvals and is expected to adjacent successful the archetypal 4th of 2026. Pfizer’s exit comes arsenic the institution braces for a much hard stretch. In December, it warned that the years up could beryllium bumpy, starting successful 2026, pointing to weaker income of its COVID vaccine and treatment, terms cuts promised to the US government, and the nonaccomplishment of patent extortion connected respective cardinal drugs. Pfizer does not expect to instrumentality to gross maturation until 2029.

In abstracted Reuters reporting, Pfizer CEO Albert Bourla said connected January 12 that the institution is preparing for a consumer-driven obesity cause marketplace that could rival the surge it experienced aft launching Viagra successful 1998. Bourla said that adjacent during talks to get weight-loss drugmaker Metsera, announced successful September 2025, Pfizer did not expect the cash-pay obesity market, present led by Eli Lilly and Novo Nordisk, to turn truthful quickly.

Pfizer developed and sold Viagra for years earlier spinning disconnected the concern that controls the marque successful 2020. The cause is present sold mostly successful generic form.

Pfizer Inc. (NYSE:PFE) is simply a global, research-based biopharmaceutical institution focused connected discovering, developing, and commercializing medicines worldwide.

While we admit the imaginable of PFE arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you’re looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

READ NEXT: 13 Best Dividend Kings to Buy successful 2026 and 14 Best Mid Cap Dividend Aristocrat Stocks to Buy Now

Disclosure: None.